Genus plc (LON: GNS)

Market Cap	1.11B
Revenue (ttm)	668.80M
Net Income (ttm)	7.90M
Shares Out	65.69M
EPS (ttm)	0.12
PE Ratio	141.68
Forward PE	23.60
Dividend	0.32 (1.90%)
Ex-Dividend Date	Nov 7, 2024

Volume	67,225
Open	1,714.00
Previous Close	1,686.00
Day's Range	1,644.00 - 1,714.00
52-Week Range	1,478.00 - 2,378.00
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 3,500
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GNS

Financial Performance

In 2024, Genus's revenue was 668.80 million, a decrease of -3.03% compared to the previous year's 689.70 million. Earnings were 7.90 million, a decrease of -76.28%.